BMS’ MS therapy Zeposia and AbbVie’s JAK inhibitor Rinvoq among latest approvals More: SMC approves funding for four new medicines on the NHS Source: News
read morePfizer to nearly halve COVID-19 vaccine production timeline, sterile injectables VP says fkansteiner Mon, 02/08/2021 – 11:12 More: Pfizer to nearly halve COVID-19 vaccine production timeline, sterile injectables VP says Source: fierce
read moreWatch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rival aliu Mon, 02/08/2021 – 10:41 More: Watch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rival Source: fierce
read moreNovartis’ 2021 access goal: solutions as ‘innovative as the science itself’ esagonowsky Mon, 02/08/2021 – 10:20 More: Novartis' 2021 access goal: solutions as 'innovative as the science itself' Source: fierce
read moreAstraZeneca, Oxford race to update COVID-19 vaccine as study flags weak action against variant aliu Mon, 02/08/2021 – 07:27 More: AstraZeneca, Oxford race to update COVID-19 vaccine as study flags weak action against variant Source: fierce
read moreImmunotherapy has previously failed in this therapy area More: AZ’s Imfinzi fails to improve overall survival in head and neck cancer again Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals